Skip to main content
. 2021 Apr 9;3(1):vdab058. doi: 10.1093/noajnl/vdab058

Figure 2.

Figure 2.

Duration of response per patient assessed by IRC. a The patient was assessed by independent reviewers as having equivocal progressive disease on day 39 prior to attaining a partial response according to RANO criteria at day 249, which permit a partial response after progressive disease that is not unequivocal. The last dose of radiotherapy was given 5.4 months prior to the first dose of bintrafusp alfa. IRC, independent review committee; PD, progressive disease; PR, partial response.